1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Dementia Associated With Alzheimer%s Disease Global Clinical Trials Review, H1, 2016

Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2016" provides an overview of Dementia Associated With Alzheimer's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia Associated With Alzheimer's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Dementia Associated With Alzheimer%s Disease Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Dementia Associated With Alzheimer's Disease to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Dementia Associated With Alzheimer's Disease to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 131
Abbreviations 131
Definitions 131
Research Methodology 132
Secondary Research 132
About GlobalData 133
Contact Us 133
Disclaimer 133
Source 134

List of Tables
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials by Region, 2016* 6
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Dementia Associated With Alzheimer's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 16
Dementia Associated With Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Dementia Associated With Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Dementia Associated With Alzheimer's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 20
Dementia Associated With Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Dementia Associated With Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials by Phase, 2016* 23
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Dementia Associated With Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32

List of Figures
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Dementia Associated With Alzheimer's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Dementia Associated With Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Dementia Associated With Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Dementia Associated With Alzheimer's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 19
Dementia Associated With Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Dementia Associated With Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24
Dementia Associated With Alzheimer's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Dementia Associated With Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Dementia Associated With Alzheimer's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32
GlobalData Methodology 132

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Alzheimer’s disease ...

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Amyotrophic lateral sclerosis (ALS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

"Global Multi Infarct Dementia Market Research Report 2016" by OBRC, is an extensive study on present state of the Multi Infarct Dementia Market. The global multi-infarct dementia is estimated to reach ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.